Biological seed treatment products help protect seeds from diseases, pests, and other environmental stresses. Some key advantages of biological seed treatments include reduced dependence on chemical pesticides, improved productivity, and enhanced plant health and vigor.
The global Biological Seed Treatment Market is estimated to be valued at US$ 1366.86 Bn in 2023 and is expected to exhibit a CAGR of 11% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
The increasing adoption of biological seed treatment products can be attributed to rising concerns towards sustainable and eco-friendly agricultural practices. Farmers are increasingly adopting biological seed treatment options like microbials and botanicals as an alternative to chemical-based seed treatments due to growing awareness about hazards of pesticide residues. Biological seed treatments are considered more environment-friendly and helps boost crop immunity rather than solely relying on pest protection. Organizations are also educating farmers about various benefits of biological seed treatment through training programs which is driving its adoption across major cropping regions.
Segment Analysis
The global biological seed treatment market can be segmented into crop type and treatment type. The crop type segment is further divided into corn, wheat, soybean, vegetables, and others. The corn sub-segment currently dominates the market due to its extensive cultivation worldwide and increasing demand for hybrid corn seeds with biological seed treatment. The treatment type segment is further classified into microbes, botanical extracts, and others. The microbes sub-segment holds the largest market share owing to its effectiveness in improving crop health and productivity.
Key Takeaways
The global Biological Seed Treatment Market Demand is expected to witness high growth during the forecast period of 2024 to 2031. The global Biological Seed Treatment Market is estimated to be valued at US$ 1366.86 Bn in 2023 and is expected to exhibit a CAGR of 11% over the forecast period 2024 to 2031.
Regional analysis shows that North America currently dominates the market due to large-scale agriculture and rising awareness about sustainable farming practices among farmers in the region. Key players in North America are focusing on innovations and product launches to consolidate their market position. The Asia Pacific region is projected to be the fastest growing market for biological seed treatment during the forecast period. This can be attributed to the increasing agricultural productivity pressure in densely populated countries such as India and China. Furthermore, supportive government initiatives for adoption of bio-products in agriculture are expected to drive the market in the Asia Pacific region.
Key players operating in the biological seed treatment market are Acelity L.P. Inc., Allergan Plc., Athersys, Inc., B. Braun, BioMimetic Therapeutics, Bio Tissue Technologies, C. R. Bard, International Stem Cell, Integra Lifesciences, Medtronic, Inc., Organogenesis Inc., Osiris Therapeutics, RTI surgical, Inc., Stryker Corporation, Tissue Regenix Group Plc., and Zimmer Biomet.
Explore more related article on this topic: https://www.pressreleasebulletin.com/biological-seed-treatment-market-demand/
Explore more related articles: https://lotstoexpress.com/whispers-of-the-genomics-exploring-the-secrets-hidden-in-every-stand/
https://blogger-veritas.blogspot.com/2024/01/the-global-medical-probiotics-market.html
Comments
0 comment